Newborn Hearing Screening - An Implementation Analysis

J 2024

Newborn Hearing Screening - An Implementation Analysis

KOSTLIVY, Tomas, Petr SKOPEK, Pavel KLAIL, Hana LAIEROVA, Alena SKALOVA et. al.

Základní údaje

Originální název

Newborn Hearing Screening - An Implementation Analysis

Autoři

KOSTLIVY, Tomas (203 Česká republika), Petr SKOPEK (203 Česká republika), Pavel KLAIL (203 Česká republika), Hana LAIEROVA (203 Česká republika), Alena SKALOVA (203 Česká republika), Břetislav GÁL (203 Česká republika, domácí), Radek KUCERA (203 Česká republika), Vaclav SIMANEK (203 Česká republika) a David SLOUKA (203 Česká republika)

Vydání

In vivo, ATHENS, Greece : International Institute of Anticancer Research, 2024, 0258-851X

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30206 Otorhinolaryngology

Stát vydavatele

Řecko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 2.300 v roce 2022

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.21873/invivo.13650

UT WoS

001266321000049

Klíčová slova anglicky

Newborn; hearing screening; hearing loss treatment

Štítky

14110126, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 15. 8. 2024 10:22, Mgr. Tereza Miškechová

Anotace

V originále

Background/Aim: Hearing impairment affects a small but significant percentage of newborns (0.1-0.4%). Newborn hearing screening (NHS) is recommended for early detection and treatment. The implementation of NHS can vary among countries. In this study, we present the methodology, organization, and technical requirements of NHS. This study analyzed results from a tertiary hospital, identified issues, and proposed solutions. Patients and Methods: In the studied region, there are five maternity hospitals and a perinatal intensive care center and in 2020, there were 5,864 live births. Screening is performed at three levels. The first screening is conducted on the 2nd-3rd day of a newborn's life in a maternity hospital, the first rescreening on the 3rd-6th week at a relevant ENT department, and the second rescreening on the 3rd-6th month of life at the regional screening center where the central database is also held. Results: In the studied region, 5,793 out of 5,864 (98.79%) newborns received NHS in 2020. Of these, 120 (2.07%) were tested positive on their first screening. Ninetyfour patients (78.3%) of those attended the ENT department for a first rescreening. Thirty-four patients (0.59% of total) were tested positive again and referred to the regional screening center. Out of the 27 patients who attended the second rescreening, four (0.07% of the total) were ultimately diagnosed with hearing impairment. Conclusion: Our study found that newborn hearing screening (NHS) in our region achieved a high compliance rate of 98.8% for initial screenings in 2020. However, challenges remain in the rescreening process due to data management issues, interregional cooperation, and public awareness. The recent implementation of mandatory screenings, updated guidelines, and a centralized database is expected to enhance the effectiveness of NHS. Further research is needed to evaluate these improvements.

Citovat

KOSTLIVY, Tomas, Petr SKOPEK, Pavel KLAIL, Hana LAIEROVA, Alena SKALOVA, Břetislav GÁL, Radek KUCERA, Vaclav SIMANEK a David SLOUKA. Newborn Hearing Screening - An Implementation Analysis. In vivo. ATHENS: Greece : International Institute of Anticancer Research, 2024, roč. 38, č. 4, s. 1939-1946. ISSN 0258-851X. Dostupné z: https://dx.doi.org/10.21873/invivo.13650.

@article{2423153,
   author = {Kostlivy, Tomas and Skopek, Petr and Klail, Pavel and Laierova, Hana and Skalova, Alena and Gál, Břetislav and Kucera, Radek and Simanek, Vaclav and Slouka, David},
   article_location = {ATHENS},
   article_number = {4},
   doi = {http://dx.doi.org/10.21873/invivo.13650},
   keywords = {Newborn; hearing screening; hearing loss treatment},
   language = {eng},
   issn = {0258-851X},
   journal = {In vivo},
   title = {Newborn Hearing Screening - An Implementation Analysis},
   url = {https://iv.iiarjournals.org/content/38/4/1939},
   volume = {38},
   year = {2024}
}

TY  - JOUR
ID  - 2423153
AU  - Kostlivy, Tomas - Skopek, Petr - Klail, Pavel - Laierova, Hana - Skalova, Alena - Gál, Břetislav - Kucera, Radek - Simanek, Vaclav - Slouka, David
PY  - 2024
TI  - Newborn Hearing Screening - An Implementation Analysis
JF  - In vivo
VL  - 38
IS  - 4
SP  - 1939-1946
EP  - 1939-1946
PB  - Greece : International Institute of Anticancer Research
SN  - 0258851X
KW  - Newborn
KW  - hearing screening
KW  - hearing loss treatment
UR  - https://iv.iiarjournals.org/content/38/4/1939
N2  - Background/Aim: Hearing impairment affects a small but significant percentage of newborns (0.1-0.4%). Newborn hearing screening (NHS) is recommended for early detection and treatment. The implementation of NHS can vary among countries. In this study, we present the methodology, organization, and technical requirements of NHS. This study analyzed results from a tertiary hospital, identified issues, and proposed solutions. Patients and Methods: In the studied region, there are five maternity hospitals and a perinatal intensive care center and in 2020, there were 5,864 live births. Screening is performed at three levels. The first screening is conducted on the 2nd-3rd day of a newborn's life in a maternity hospital, the first rescreening on the 3rd-6th week at a relevant ENT department, and the second rescreening on the 3rd-6th month of life at the regional screening center where the central database is also held. Results: In the studied region, 5,793 out of 5,864 (98.79%) newborns received NHS in 2020. Of these, 120 (2.07%) were tested positive on their first screening. Ninetyfour patients (78.3%) of those attended the ENT department for a first rescreening. Thirty-four patients (0.59% of total) were tested positive again and referred to the regional screening center. Out of the 27 patients who attended the second rescreening, four (0.07% of the total) were ultimately diagnosed with hearing impairment. Conclusion: Our study found that newborn hearing screening (NHS) in our region achieved a high compliance rate of 98.8% for initial screenings in 2020. However, challenges remain in the rescreening process due to data management issues, interregional cooperation, and public awareness. The recent implementation of mandatory screenings, updated guidelines, and a centralized database is expected to enhance the effectiveness of NHS. Further research is needed to evaluate these improvements.
ER  -

KOSTLIVY, Tomas, Petr SKOPEK, Pavel KLAIL, Hana LAIEROVA, Alena SKALOVA, Břetislav GÁL, Radek KUCERA, Vaclav SIMANEK a David SLOUKA. Newborn Hearing Screening - An Implementation Analysis. \textit{In vivo}. ATHENS: Greece : International Institute of Anticancer Research, 2024, roč.~38, č.~4, s.~1939-1946. ISSN~0258-851X. Dostupné z: https://dx.doi.org/10.21873/invivo.13650.

Podrobný výpis o publikaci